维普中文期刊产品整合服务
29篇 您的检索式:作者名="BOBOS G"
    题名 作者 年代 出处 被引量
1Primary pancreatic anaplastic large cell lymphoma, ALK negative: A case report显示文摘We present the fourth case of a primary pancreatic anaplastic large cell lymphoma (ALCL), ALK-. An 80-year-old man was admitted to our clinic for further investigation of a fever of unknown origin. He noted anorexia, weight loss and fatigue. His laboratory tests showed anemia and a great elevation of ESR, LDH, and β2 microglobulin. In CT and MRI scan, a soft tissue mass in the pancreas was observed. A repeated endoscopy after his admission revealed an ulcerated mass-like deformity of the duodenal bulb. Explorative laparotomy confirmed a diffuse spread of an unresectable malignant pancreatic mass extending to the adjacent organs. Duodenal and surgical biopsies identified an ALCL of T-cell lineage, ALK-. The patient died in the Intensive Care Unit due to hemodynamic instability.Our case is the first one indicating that primary pancreatic lymphoma should be suspected in a patient with pancreatic mass and elevated serum LDH and β2 microglobulin.Christos G Savopoulos NE Tsesmeli GD Kaiafa AT Zantidis MT Bobos AI Hatzitolios ST Papavramidis IS Kostopoulos 2005World Journal of Gastroenterology2005,11,39:3
2Induction chemotherapyfollowed by concomitant radiotherapy and weekly cisplatin versusthe sameconcomitant chemoradiotherapy in patients with nasopha-ryngeal carcinoma: a randomized phase II studyconducted by theHellenic Cooperative Oncology Group (HeCOG) with biomarkerevaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Arm Oncol2012,23,2:1
3Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients显示文摘Krikelis D Bobos M Karayannopoulou G 2013BMC Clin Pathol2013,13,:1
4Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oneology Group with biomarker evaluation显示文摘Fountzilas G Bobos M Kalogera-Fountzila A 2008Cancer Invest2008,26,8:1
5Rimonabant reduces obesity- associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats显示文摘Gary - Bobo M Elachouri G Gallas JF 2007Hepatology2007,46,1:1
6Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemora- diotherapy in patients with nasopharyngeal carcinoma:a randomized phase 11 study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation 显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
7Gemcitabinecombined with gefitinib in patients with inoperable or metastaticpancreatic cancer:a phase II Study of the Hellenic CooperativeOncology Group with biomarker evaluation显示文摘Fountzilas G Bobos M Kalogera-Fountzila A 2008Cancer Invest2008,26,8:1
8Telomere dysfunc- tion causes sustained inflammation in chronic obstructive puhnona- rydisease显示文摘Amsellem V Gary - Bobo G Marcos E 2011Am J Respir Crit Care Med2011,184,12:1
9Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma:a randomized phase II study conducted by the Hellenic Cooperative Oncology Group(HeCOG)with biomarker evaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Annals of oncology2012,23,2:1
10Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma:a randomized phase II study conducted by the Hellenic Cooperative Oncology Group(He COG)with biomarker evaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
11Immunohistochemical investigation of CD34 antigen in male breast carcinoma 显示文摘Milias S Kalekou H Bobos M Karayannopoulou G Gerasimidou D Nenopoulou H Panoussi E Kostopoules I 2007Clin Exp Med2007,7,3:1
12Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma:a randomized phase Ⅱ study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,:1
13Modification of surface charge properties during kaolinite to halloysite 7 angstrom transformation显示文摘TARI G BOBOS I GOMES CSF 1999Journal of Colloid and Interface Science1999,210,2:1
14Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer:a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation显示文摘Fountzilas G Bobos M Kalogera-Fountzila A 2008Cancer Invest2008,26,8:1
15Differential response of im- munohistochemically defined breast cancer subtypes to anthracy- cline - based adjuvant chemotherapy with or without paclitaxel 显示文摘Fountzilas G Dafni U Bobos M 2012PIS One2012,7,37:1
16Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopha- ryngeal carcinoma: a randomized phase H study conducted by the Hellenic Cooperatiye Oncology Group (HeCOG) with biomarker e- valuation 显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
17Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase Ⅱ alpha gene status and protein expression in patients with breast cancer treated with anthracycline - containing adjuvant chemother- apy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase Ⅲ trials显示文摘FOUNTZILAS G DAFNI U BOBOS M 2013BMC Cancer2013,13,:1
18Induction chemothera-py followed by concomitant radiotherapy and weekly cisplatin ver-sus the same concomitant chemoradiotherapy in patients with naso-pharyngeal carcinoma : a randomized phase II study conducted bythe Hellenic Cooperative Oncology Group (HeCOG) with biomark-er evaluation显示文摘Fountzilas G Ciuleanu E Bobos M 2012Ann Oncol2012,23,2:1
19Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab 显示文摘Fountzilas G Christodoulou C Bobos M 2012Journal of translational medicine2012,10,1:1
20Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group ( HeCOG ) phase 111 trims 显示文摘Fountzilas G Dafni U Bobos M 2013BMC cancer2013,13,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费